Mayo Clinic trial to use stem cells to treat infant heart defects

The Mayo Clinic has received federal approval for a trial that will use autologous umbilical cord stem cells to treat hypoplastic left heart syndrome. The trial will commence upon the enrollment of 10 eligible patients, who will undergo three repair surgeries.

View Full Article in:

Star Tribune (Minneapolis-St. Paul, Minn.) · KTTC-TV (Minn)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC